AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 270 filers reported holding AVANOS MED INC in Q1 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $226,000 | -7.8% | 6,760 | -4.4% | 0.00% | 0.0% |
Q4 2021 | $245,000 | +10.4% | 7,069 | -0.9% | 0.00% | 0.0% |
Q3 2021 | $222,000 | -11.6% | 7,133 | +3.3% | 0.00% | 0.0% |
Q2 2021 | $251,000 | -15.2% | 6,904 | +2.0% | 0.00% | 0.0% |
Q1 2021 | $296,000 | -9.8% | 6,770 | -5.4% | 0.00% | 0.0% |
Q4 2020 | $328,000 | +39.6% | 7,158 | +0.8% | 0.00% | 0.0% |
Q3 2020 | $235,000 | +9.8% | 7,100 | -2.8% | 0.00% | 0.0% |
Q2 2020 | $214,000 | +5.4% | 7,307 | -3.3% | 0.00% | 0.0% |
Q1 2020 | $203,000 | -30.7% | 7,559 | -13.3% | 0.00% | 0.0% |
Q4 2019 | $293,000 | -19.7% | 8,723 | -10.7% | 0.00% | -50.0% |
Q3 2019 | $365,000 | -19.6% | 9,766 | -6.2% | 0.00% | 0.0% |
Q2 2019 | $454,000 | 0.0% | 10,414 | -2.3% | 0.00% | 0.0% |
Q1 2019 | $454,000 | -10.1% | 10,657 | -5.5% | 0.00% | -33.3% |
Q4 2018 | $505,000 | -34.9% | 11,278 | -0.5% | 0.00% | -25.0% |
Q3 2018 | $776,000 | – | 11,335 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |